Article -> Article Details

Market Highlights

The global varicocele treatment market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Varicocele is an enlargement of the veins within the scrotum, the scrotum is a skin-covered loose bag that holds testicles. Increasing number of varicocele, availability of effective treatments, and increasing awareness are leading the growth for the market. The other. Advanced diagnostics and treatment are key factors for the market growth. The increasing demand from emerging economies of Asia are driving the growth for the market. Hospitals, researchers and academic institutes are continuously doing research to derive effective cure for varicocele that is another important factor for the growth of global varicocele treatment market.

The market for varicocele treatment was around USD 405.3 million in 2016 and is expected to reach USD 617.5 million by 2023 which is a projected CAGR of 6.2%.

Taste the market data and market information presented through more than 54 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC market synopsis on “Varicocele Treatment Market Research Report–Global Forecast to 2023.”

Major players in Varicocele treatment market:

There are plenty of large and small market players which operate in this market: Bayer (Germany), Depomed, Inc. (US), GlaxoSmithKline plc. (UK), INSYS THERAPEUTICS, INC. (US), Janssen Global Services, LLC (Belgium) Mylan N.V. (US), Novartis AG (Switzerland), PurduePharma (US), Pfizer Inc. (US), and others.

Regional Analysis:

Considering the global scenario of the varicocele treatment market, there are four main regions- America, Europe, Asia Pacific, and Middle East Africa. The Americas are holding largest market share. The Americas mainly include North America and Latin America. North America is largest and top revenue generator market for varicocele treatment. Europe is second largest market. Germany, UK, and France are the major markets while Eastern European varicocele treatment market is also growing. Asia Pacific varicocele treatment is also growing significantly. Some major factors like increasing awareness of the disease, developing healthcare sector, and rising healthcare expenditure are driving the growth for Asia Pacific varicocele treatment market. Middle East Africa varicocele treatment market is expected to have limited growth mainly due to lack of knowledge of the disorder, and limited access to the healthcare facilities. Due to developed healthcare infrastructure and high expenditure on healthcare, Middle East is dominating region as compared to Africa.

Segmentation:

Global Varicocele treatment market has been segmented on the basis of grade which comprise grade I, grade II, grade III, and others.

On the basis of diagnosis it is segmented into physical exam, imaging test, and others. Imaging test further sub-segmented into thermography, scrotal ultrasound, and others

On the basis of treatments, the market has been segmented into varicocele repair, varicocele embolization, medication, and others. Varicocele repair is sub-segmented into open surgery, laparoscopic surgery, percutaneous embolization, and others. Medication is sub-segmented into painkillers, and others. Painkillers includes acetaminophen, ibuprofen, and others.

On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.